Literature DB >> 15681774

CCL25 enhances CD103-mediated lymphocyte adhesion to E-cadherin.

Anna Ericsson1, Anu Arya, William Agace.   

Abstract

Our results demonstrate that (1) CD103 is upregulated on CD8(+) T cells subsequent to their entry into the small intestinal epithelium, and (2) that the chemokine CCL25 enhances CD103-mediated adhesion to E-cadherin. These results suggest a novel role for chemokines in modulating interactions between lymphocytes and epithelial cells at mucosal surfaces.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15681774     DOI: 10.1196/annals.1309.014

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

Review 1.  Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there.

Authors:  Christopher C Denucci; Jason S Mitchell; Yoji Shimizu
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

2.  Oral infection drives a distinct population of intestinal resident memory CD8(+) T cells with enhanced protective function.

Authors:  Brian S Sheridan; Quynh-Mai Pham; Young-Tae Lee; Linda S Cauley; Lynn Puddington; Leo Lefrançois
Journal:  Immunity       Date:  2014-05-01       Impact factor: 31.745

Review 3.  T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.

Authors:  Robert Sackstein; Tobias Schatton; Steven R Barthel
Journal:  Lab Invest       Date:  2017-03-27       Impact factor: 5.662

Review 4.  The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies.

Authors:  Iris Dotan; Matthieu Allez; Silvio Danese; Mary Keir; Swati Tole; Jacqueline McBride
Journal:  Med Res Rev       Date:  2019-06-19       Impact factor: 12.944

Review 5.  Integrin αE(CD103)β7 in Epithelial Cancer.

Authors:  Johanna C Hoffmann; Michael P Schön
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.